Pharmadigit is an Algerian startup positioning itself as the primary digital infrastructure for the country’s pharmaceutical sector. The deck highlights a significant market opportunity, citing a $4 billion drug market and a $3 billion parapharmacy market. Having already raised $100,000 from the Algerian Startup Fund (ASF) in May 2021, the company is now seeking $2,000,000 to scale its e-commerce marketplace, secure online payment systems, and logistics network. While the deck successfully establishes the scale of the Algerian market—45 million people and 24 million internet users—it suffers…
Key takeaways
- The company identifies a total addressable market in Algeria worth $7 billion across drugs and medical consumables (Slide 3).
- Pharmadigit has already secured $100,000 in seed capital from the Algerian Startup Fund as of May 2021 (Slide 7).
- The startup is the first pharmaceutical startup labeled by the Algerian Ministry of Knowledge and Startups (Slide 7).
- The business model relies on three pillars: a sourcing solution for better pricing, a digital payment platform, and express logistics (Slide 4).
- Target reach includes 58 wilayas (provinces) and a pool of 9 million bank card holders (Slide 5).
- The current funding requirement is stated as $2,000,000 with a 4-year timeline (Slide 8).
- The deck lacks a dedicated team slide with names or specific bios, despite claiming 'accomplished management' (Slide 2).
- Significant typographical and grammatical errors throughout the deck may impact investor confidence in professional execution.
Pharmadigit Pitch Deck Analysis
Pharmadigit is navigating a high-potential but technologically underserved market: the Algerian pharmaceutical supply chain. The deck, titled 'Pitch Deck Presentation Pharmadigit 2022,' serves as a roadmap for a company attempting to transition a traditional $7 billion industry into the digital age. By securing early backing from the Algerian government's startup fund, they have established a level of local legitimacy that is rare in emerging markets. However, the deck itself is a mix of impressive macro statistics and a lack of micro-level operational detail.
Slide 1: Title and Positioning
The cover slide introduces Pharmadigit with the tagline 'Digital Pharmacie to make your life easier.' The imagery focuses on the consumer experience—a laptop showing 'Medical Delivery' and a hand holding a credit card. This immediately signals that the company is not just a B2B logistics firm but an end-to-end e-commerce and payment platform. The design is clean, though the left-hand navigation bar (Resources, About us, Contact) suggests this may have been adapted from a website template or a multi-purpose corporate presentation rather than a bespoke investor deck.
Slide 2: About Us and Value Proposition
Slide 2 attempts to establish the company's identity through five pillars: Best Company, Best Marketplace, Great Service, Growing Company, and Good Managemnet (sic). The slide claims Pharmadigit is the '1st Company with spesific service' and that it makes digitization a 'strategic axis.' While the intent is to show breadth, the descriptions are generic. For example, 'Great Service' is described as making the customer feel like they 'found a friend.' In a professional fundraising context, investors typically look for more concrete differentiators, such as proprietary software or exclusive distribution rights, rather than emotional appeals. The mention of 'experienced and accomplished management' is a significant claim that requires a dedicated team slide to validate, which is missing from this selection.
Slide 3: Market Overview and Statistics
This is arguably the strongest slide in the deck. It provides a clear, data-driven snapshot of the Algerian market using 2022 figures from the Ministry of Pharmaceutical Industry. The stats are compelling: 13,000 pharmacists and 700 private clinics represent a massive B2B customer base. The market value is segmented into $4 billion for drugs and $3 billion for parapharmacy/consumables. By highlighting that 24 million people are 'connected' (internet users), Pharmadigit justifies the move toward a digital marketplace. This slide successfully answers the 'Why now?' and 'How big?' questions that investors prioritize.
Slide 4: Service Workflow
Slide 4 breaks down the business model into three distinct phases: Sourcing, Digital, and Logistics. Phase 01 (Sourcing) involves distribution contracts with producers and importers to ensure better pricing. Phase 02 (Digital) focuses on the user experience and 'seccure online payment.' Phase 03 (Logistics) covers storage and express delivery. This indicates that Pharmadigit is an inventory-heavy or at least logistics-integrated marketplace, rather than a pure software-as-a-service (SaaS) play. The mention of 'renewable data' to analyze needs suggests an intent to use data analytics, though the term is slightly non-standard in this context.
Slide 5: Product and Target Demographics
This slide connects the product features to specific market targets. The E-commerce Marketplace targets the 24 million internet users. The 'seccured Online Paiement' (sic) targets the 9 million bank card holders in the country. The logistics service aims for 'coverage of 58 wilayas.' This is a critical slide because it demonstrates geographic ambition. Algeria is a large country, and promising coverage of all 58 provinces is a significant operational undertaking that explains the need for a $2 million investment.
Slide 6: Online Presence and Consumer Behavior
Slide 6 reinforces the shift in consumer behavior. It notes that 'online sales have become the easiest method for consumers' and reiterates the 24 million Algerian web users figure. The imagery of a businessman holding a tablet with data overlays (showing 94.05% and various charts) is intended to evoke a high-tech, data-driven approach. The text emphasizes that consumers are 'increasingly busy,' which drives the demand for delivery services.
Slide 7: Fundraising History (Traction)
Titled 'Rised Capital,' this slide provides the company's historical funding. It states that Pharmadigit 'rised' $100,000 USD from the ASF (Algerian Startup Fund) in May 2021. This is a vital piece of social proof. Being the 'First Pharmaceutical startup labellised by the Ministry' and the '04 th startup' to raise from the ASF suggests that the company has passed government due diligence and is a leader in the local tech ecosystem. This traction slide helps mitigate the perceived risk of operating in an emerging market.
Slide 8: The Ask
The final slide in this set presents the 'Funding Requirement' of $2,000,000 USD and a 'Funding Timeline' of 4 years. The imagery of coins in a jar with a growing plant is a standard metaphor for investment growth. While the figure is clear, the slide lacks a 'Use of Funds' breakdown. Investors generally want to know what percentage of that $2M goes to warehouse infrastructure, fleet acquisition, software development, or marketing.
What Pharmadigit Does Well
The deck excels at defining a large, untapped market. By citing specific government statistics (Slide 3), the founders move beyond guesswork and provide a solid foundation for the $7 billion market claim. The focus on the '58 wilayas' (Slide 5) shows an understanding of the local administrative and geographic landscape, which is essential for a logistics-based business. Furthermore, the inclusion of the ASF funding (Slide 7) provides immediate credibility; it proves that the founders can navigate the local regulatory environment and have already convinced one institutional body to back them.
What is Missing from the Deck
The most glaring omission is a detailed Team Slide. While Slide 2 mentions 'experienced management,' there are no names, photos, or career histories to back this up. In early-stage investing, the 'who' is often as important as the 'what.' Additionally, the deck lacks any mention of unit economics. There is no information on the average order value (AOV), the commission percentage Pharmadigit takes from importers, or the cost to deliver a package. Without these, the $2 million ask feels arbitrary. Finally, there is no competitive landscape. Even if they are the 'first' digital solution, they are still competing against traditional wholesalers and informal delivery networks.
Recommendations for Founders
1. Fix the Language and Typos: The deck contains numerous spelling errors ('spesific,' 'Managemnet,' 'seccured,' 'Paiement,' 'rised'). While this may seem minor, it can signal a lack of attention to detail to international investors. A thorough proofread is mandatory.
2. Detailed Use of Funds: A $2 million ask is significant for a regional startup. Founders should include a slide breaking down how this money will be spent over the 4-year timeline mentioned on Slide 8. Will $1M go to a central warehouse? Will $500k go to a fleet of delivery bikes?
3. Show, Don't Just Tell, the Management: Replace the generic 'Good Management' box on Slide 2 with a dedicated slide featuring headshots and 2-sentence bios of the founders. Highlight any specific experience in pharmacy, logistics, or software development.
4. Define the Revenue Model: Clearly state how the company makes money. Is it a markup on products, a transaction fee on the marketplace, or a subscription fee for pharmacists? Slide 4 hints at sourcing contracts, but the mechanics of the 'Digital Solution' revenue need to be explicit.
5. Address the Regulatory Environment: Pharmaceutical markets are heavily regulated. A slide explaining how Pharmadigit complies with Algerian health laws regarding the transport and sale of prescription drugs would be highly valuable for risk assessment.
Frequently asked questions
- What is Pharmadigit's primary value proposition?
- Pharmadigit positions itself as the 'first digital solutions company' to digitize the pharmaceutical market in Algeria. According to slide 4, they provide a three-part service: sourcing products at better prices through direct contracts with importers, providing a secure online payment experience, and managing quality storage and express delivery logistics. They aim to bridge the gap between 950 producers/importers and 13,000 pharmacists.
- How much capital has the company raised to date?
- As stated on slide 7, Pharmadigit raised $100,000 USD in May 2021. This capital was provided by the ASF (Algerian Startup Fund), which the deck describes as the first capital risk fund in Algeria. The company claims to be the fourth startup to ever raise capital from this specific fund, highlighting their early-mover advantage in the local ecosystem.
- What are the specific market statistics for Algeria mentioned in the deck?
- Slide 3 cites data from the Ministry of Pharmaceutical Industry 2022. The market consists of 45 million people, 13,000 pharmacists, 950 producers/importers, 80,000 health professionals, and 700 private clinics. The financial value is split between a $4 billion drug market and a $3 billion parapharmacy and medical consumable market, totaling a $7 billion opportunity.
- What is the current funding ask and how will it be used?
- Slide 8 explicitly states a 'Funding Requirement' of $2,000,000 USD. The slide also mentions a 'Funding Timeline' of 4 years. While the deck does not provide a granular breakdown of spend (e.g., marketing vs. R&D), slide 5 suggests the goals include achieving coverage across all 58 wilayas and capturing a share of the 9 million bank card users.
- Does the deck include a competitive analysis or financial projections?
- No. The 8 slides provided do not contain a competitive landscape, revenue projections, or current traction metrics beyond the initial funding. It also omits unit economics, such as the take rate on marketplace transactions or delivery fees. Investors would need to see these details to validate the $2 million valuation or investment terms.
